Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$3.69B |
| 2 |
Abbott
ABT
|
+$3.65B |
| 3 |
Qualcomm
QCOM
|
+$3.54B |
| 4 |
Procter & Gamble
PG
|
+$3.42B |
| 5 |
Accenture
ACN
|
+$3.28B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$2.86B |
| 2 |
AbbVie
ABBV
|
+$2.71B |
| 3 |
Valero Energy
VLO
|
+$1.86B |
| 4 |
Lockheed Martin
LMT
|
+$916M |
| 5 |
Halliburton
HAL
|
+$856M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 10.68% |
| 3 | Healthcare | 10.19% |
| 4 | Industrials | 8.63% |
| 5 | Consumer Discretionary | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Crane NXT
CXT
$3.06B
| $18.8M | ﹤0.01% |
464,149
+34,351
| +8% | +$1.67M |
|
1777
Edgewise Therapeutics
EWTX
$4.48B
| $18.8M | ﹤0.01% |
596,310
-15,074
| -2% | -$435K |
|
1778
Rush Street Interactive
RSI
$3.26B
| $18.8M | ﹤0.01% |
863,409
+15,614
| +2% | +$299K |
|
1779
Braze
BRZE
$2.73B
| $18.8M | ﹤0.01% |
794,568
+73,077
| +10% | +$1.58M |
|
1780
Open Text
OTEX
$5.79B
| $18.7M | ﹤0.01% |
842,525
+78,515
| +10% | +$2.04M |
|
1781
Ambarella
AMBA
$2.85B
| $18.7M | ﹤0.01% |
363,291
-1,928
| -0.5% | -$120K |
|
1782
Gray Television
GTN
$414M
| $18.6M | ﹤0.01% |
4,295,148
-893,564
| -17% | -$4.2M |
|
1783
Immunome
IMNM
$2.61B
| $18.6M | ﹤0.01% |
851,789
+11,100
| +1% | +$247K |
|
1784
QuantumScape Corp
QS
$3.12B
| $18.6M | ﹤0.01% |
2,915,375
+77,539
| +3% | +$644K |
|
1785
Ezcorp Inc
EZPW
$1.85B
| $18.6M | ﹤0.01% |
731,982
+24,565
| +3% | +$589K |
|
1786
GSK
GSK
$105B
| $18.6M | ﹤0.01% |
336,506
+46,618
| +16% | +$2.53M |
|
1787
Dime Commercial Bancshares
DCOM
$1.76B
| $18.6M | ﹤0.01% |
548,615
+13,017
| +2% | +$428K |
|
1788
Koppers
KOP
$953M
| $18.5M | ﹤0.01% |
477,878
-90,535
| -16% | -$3.03M |
|
1789
Vita Coco
COCO
$3.83B
| $18.4M | ﹤0.01% |
384,968
+8,498
| +2% | +$464K |
|
1790
TriNet
TNET
$2.99B
| $18.4M | ﹤0.01% |
505,181
+19,071
| +4% | +$911K |
|
1791
TripAdvisor
TRIP
$1.67B
| $18.3M | ﹤0.01% |
1,720,680
+142,117
| +9% | +$1.65M |
|
1792
Summit Therapeutics
SMMT
$10.8B
| $18.2M | ﹤0.01% |
960,867
+68,238
| +8% | +$1.1M |
|
1793
Cracker Barrel
CBRL
$1.17B
| $18.2M | ﹤0.01% |
646,557
+99,242
| +18% | +$3.02M |
|
1794
Capital City Bank Group
CCBG
$887M
| $18.1M | ﹤0.01% |
417,183
+302,614
| +264% | +$13M |
|
1795
Rio Tinto
RIO
$148B
| $18.1M | ﹤0.01% |
194,311
+32,766
| +20% | +$2.99M |
|
1796
Reynolds Consumer Products
REYN
$5.41B
| $18.1M | ﹤0.01% |
855,333
-8,388
| -1% | -$192K |
|
1797
Eldorado Gold
EGO
$8.41B
| $18.1M | ﹤0.01% |
528,982
-30,301
| -5% | -$1.23M |
|
1798
ANI Pharmaceuticals
ANIP
$1.79B
| $18M | ﹤0.01% |
234,288
-17,341
| -7% | -$1.35M |
|
1799
Bitdeer Technologies
BTDR
$2.71B
| $18M | ﹤0.01% |
2,080,842
+477,241
| +30% | +$5.02M |
|
|
UMH
1800
UMH Properties
UMH
$1.33B
| $17.9M | ﹤0.01% |
1,242,647
+22,199
| +2% | +$344K |
|
Similar funds
Charles Schwab's Q1 2026 Portfolio in Review
As of Q1 2026, Charles Schwab held 3,535 positions worth $654B, up 1.7% from $644B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Charles Schwab deployed $21.4B of net new capital in Q1 2026, opening 79 new positions and adding to 1,903 existing holdings. Its largest new stake was JPMorgan Income ETF: 8,679,689 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Cisco, an estimated $2.86B trimmed.
- Charles Schwab's largest Q1 2026 buy was JPMorgan Income ETF: 8,679,689 shares worth $400M.
- Charles Schwab added most to UnitedHealth in Q1 2026, an estimated $3.69B increase.
- Charles Schwab's biggest Q1 2026 reduction was Cisco, cutting an estimated $2.86B.
- Charles Schwab fully exited Comerica in Q1 2026, selling an estimated $412M.
- Charles Schwab's ten largest holdings make up 22% of its $654B portfolio in Q1 2026.
- Charles Schwab opened 79 new positions and closed 80 in Q1 2026.
- Charles Schwab's portfolio value rose 1.7% quarter-over-quarter to $654B.
Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.